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Background 
In areas where anaemia is common, children are 
sometimes given iron supplements. However, iron may 
increase children’s susceptibility to malaria. A trial from 
Tanzania suggested iron is harmful. 
Inclusion criteria 
Studies:  
Randomized controlled trials. 
Participants: 
Children less than 18 years living in a malaria-endemic 
area.  
Intervention: 
Orally administered iron, excluding fortified food and 
drinks. Trials where iron supplements were combined 
with folic acid or antimalarial drugs, or where other 
micronutrients were included in both trial arms, were 
included. 
Outcomes: 
Malaria, death, anaemia, other infections.    
Results 
• Sixty-eight trials involving 42,981 children were 
included. Allocation concealment was adequate in 28 
trials. 
• Iron supplementation did not increase the risk of 
clinical malaria (relative risk 1.00, 95% confidence 
interval 0.88 to 1.13; 22,724 children, 14 trials, 
random-effects model). The risk was similar in trials 
where most children did not have anaemia, and 
where over 50% had anaemia at the start of the trial. 
• The risk of malaria parasitaemia at end of treatment 
was higher with iron for all trials (RR 1.13, 95% CI 
1.01 to 1.26; 3184 children, 8 trials), but there was no 
difference in adequately concealed trials (6 trials). 
• There was no increased risk of death across all trials 
comparing iron versus placebo (RR 1.11, 95% CI 0.91 
to 1.36; 21,272 children, 12 trials). Growth and other 
infections were not affected by iron supplementation. 
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Should young children living in malarial areas be given iron every day? 
Iron supplements do not increase the risk of malaria illness or 
death in children living in malarial areas. 
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Authors’ conclusions 
Iron supplementation does not increase the risk of clinical malaria or death in children living in malaria-endemic 
areas.  
Implications for practice:  
There are no reasons to withhold routine iron supplementation from children living in malaria-endemic countries. 
There is no need to screen for anaemia prior to iron supplementation. 
Implications for research: 
Further large well-designed trials and long-term observational studies are needed to clarify some of the remaining 
questions such as overall mortality, growth and developmental outcomes. 
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